Lesley Murray Selected Research

Lesley Murray Research Topics

7	Neoplasms (Cancer) 06/2015 - 12/2002
2	Breast Neoplasms (Breast Cancer) 05/2012 - 07/2009
1	Prescription Drug Overuse 07/2022
1	Headache (Headaches) 07/2022
1	Migraine Disorders (Migraine) 07/2022
1	Medulloblastoma 11/2010
1	Melanoma (Melanoma, Malignant) 04/2009
1	Carcinogenesis 04/2009
1	Carcinoma (Carcinomatosis) 01/2004
1	Adenocarcinoma 12/2002

2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2009 - 04/2009
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2009 - 04/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2009 - 04/2009
2	Biomarkers (Surrogate Marker)IBA 04/2009 - 01/2004
2	Contrast MediaIBA 01/2004 - 12/2002
1	erenumabIBA 07/2022
1	Calcitonin Gene-Related PeptideIBA 07/2022
1	p21-Activated KinasesIBA 06/2015
1	Caspase 3 (Caspase-3)IBA 05/2012
1	Proteins (Proteins, Gene)FDA Link 05/2012
1	Messenger RNA (mRNA)IBA 11/2010
1	diphenyl (biphenyl)IBA 11/2010
1	HhAntag691IBA 11/2010
1	AmidesIBA 11/2010
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 04/2009
1	2- (4- (1- (hydroxyimino)- 2,3- dihydro- 1H- inden- 5- yl)- 3- (pyridin- 4- yl)- 1H- pyrazol- 1- yl)ethan- 1- olIBA 04/2009
1	Mitogen-Activated Protein KinasesIBA 04/2009
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2009
1	orantinib (SU6668)IBA 01/2004
1	Phosmet (Prolate)IBA 12/2002
1	SU 11657IBA 12/2002
1	perflutren (octafluoropropane)FDA Link 12/2002
1	Formaldehyde (Formol)FDA Link 12/2002

2	Therapeutics 07/2009 - 12/2002